Abstract
Disseminated Fusarium infection is associated with high mortality in immunocompromised patients. Patients with acute myeloid leukemia (AML) often have an extended duration of neutropenia during intensive induction chemotherapy, consolidation chemotherapy, and hematopoietic stem cell transplantation (SCT). There is no consensus regarding management of invasive disseminated Fusarium infections in the setting of prolonged neutropenia (Tortorano et al., 2014) [1]. We report a case of disseminated Fusarium in a patient with relapsed AML who underwent successful chemotherapy and haplo-identical allogeneic SCT with administration of granulocyte colony stimulating factor (G-CSF) and granulocyte infusions.
Original language | English (US) |
---|---|
Pages (from-to) | 4-6 |
Number of pages | 3 |
Journal | Leukemia Research Reports |
Volume | 8 |
DOIs | |
State | Published - 2017 |
Externally published | Yes |
Keywords
- Acute myeloid leukemia
- Allogenic transplant
- Fusarium solani
ASJC Scopus subject areas
- Hematology
- Oncology